BIOGEN INC (IDP.DE) Fundamental Analysis & Valuation
FRA:IDP • US09062X1037
Current stock price
157.02 EUR
-3.76 (-2.34%)
Last:
This IDP.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IDP.DE Profitability Analysis
1.1 Basic Checks
- IDP had positive earnings in the past year.
- In the past year IDP had a positive cash flow from operations.
- Each year in the past 5 years IDP has been profitable.
- In the past 5 years IDP always reported a positive cash flow from operatings.
1.2 Ratios
- With a decent Return On Assets value of 4.39%, IDP is doing good in the industry, outperforming 77.78% of the companies in the same industry.
- IDP has a better Return On Equity (7.08%) than 79.01% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 8.93%, IDP belongs to the top of the industry, outperforming 82.72% of the companies in the same industry.
- IDP had an Average Return On Invested Capital over the past 3 years of 8.93%. This is below the industry average of 12.00%.
- The last Return On Invested Capital (8.93%) for IDP is above the 3 year average (8.93%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 7.08% | ||
| ROIC | 8.93% |
ROA(3y)4.85%
ROA(5y)6.69%
ROE(3y)8.23%
ROE(5y)12.34%
ROIC(3y)8.93%
ROIC(5y)10.93%
1.3 Margins
- With a decent Profit Margin value of 13.07%, IDP is doing good in the industry, outperforming 79.01% of the companies in the same industry.
- In the last couple of years the Profit Margin of IDP has declined.
- Looking at the Operating Margin, with a value of 27.94%, IDP belongs to the top of the industry, outperforming 85.19% of the companies in the same industry.
- In the last couple of years the Operating Margin of IDP has declined.
- IDP's Gross Margin of 75.69% is fine compared to the rest of the industry. IDP outperforms 66.67% of its industry peers.
- IDP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.94% | ||
| PM (TTM) | 13.07% | ||
| GM | 75.69% |
OM growth 3Y-3.78%
OM growth 5Y-5.27%
PM growth 3Y-24.15%
PM growth 5Y-15.17%
GM growth 3Y-0.7%
GM growth 5Y-2.57%
2. IDP.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IDP is destroying value.
- The number of shares outstanding for IDP has been increased compared to 1 year ago.
- IDP has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for IDP has been reduced compared to a year ago.
2.2 Solvency
- IDP has an Altman-Z score of 3.30. This indicates that IDP is financially healthy and has little risk of bankruptcy at the moment.
- IDP has a Altman-Z score of 3.30. This is comparable to the rest of the industry: IDP outperforms 59.26% of its industry peers.
- IDP has a debt to FCF ratio of 3.11. This is a good value and a sign of high solvency as IDP would need 3.11 years to pay back of all of its debts.
- IDP has a Debt to FCF ratio of 3.11. This is amongst the best in the industry. IDP outperforms 85.19% of its industry peers.
- A Debt/Equity ratio of 0.34 indicates that IDP is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.34, IDP is in line with its industry, outperforming 59.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 3.11 | ||
| Altman-Z | 3.3 |
ROIC/WACC0.97
WACC9.21%
2.3 Liquidity
- A Current Ratio of 2.68 indicates that IDP has no problem at all paying its short term obligations.
- The Current ratio of IDP (2.68) is comparable to the rest of the industry.
- A Quick Ratio of 2.03 indicates that IDP has no problem at all paying its short term obligations.
- IDP's Quick ratio of 2.03 is in line compared to the rest of the industry. IDP outperforms 50.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.68 | ||
| Quick Ratio | 2.03 |
3. IDP.DE Growth Analysis
3.1 Past
- IDP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.16%.
- The earnings per share for IDP have been decreasing by -14.17% on average. This is quite bad
- IDP shows a small growth in Revenue. In the last year, the Revenue has grown by 2.22%.
- The Revenue has been decreasing by -5.96% on average over the past years.
EPS 1Y (TTM)-7.16%
EPS 3Y-6.07%
EPS 5Y-14.17%
EPS Q2Q%-42.15%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y-0.93%
Revenue growth 5Y-5.96%
Sales Q2Q%-7.14%
3.2 Future
- The Earnings Per Share is expected to grow by 4.27% on average over the next years.
- The Revenue is expected to grow by 0.45% on average over the next years.
EPS Next Y5.45%
EPS Next 2Y3.4%
EPS Next 3Y3.98%
EPS Next 5Y4.27%
Revenue Next Year-3.54%
Revenue Next 2Y-1.96%
Revenue Next 3Y-0.91%
Revenue Next 5Y0.45%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. IDP.DE Valuation Analysis
4.1 Price/Earnings Ratio
- IDP is valuated correctly with a Price/Earnings ratio of 12.03.
- Based on the Price/Earnings ratio, IDP is valued cheaper than 92.59% of the companies in the same industry.
- When comparing the Price/Earnings ratio of IDP to the average of the S&P500 Index (27.42), we can say IDP is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 11.41, the valuation of IDP can be described as reasonable.
- IDP's Price/Forward Earnings ratio is rather cheap when compared to the industry. IDP is cheaper than 97.53% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of IDP to the average of the S&P500 Index (22.24), we can say IDP is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.03 | ||
| Fwd PE | 11.41 |
4.2 Price Multiples
- 90.12% of the companies in the same industry are more expensive than IDP, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, IDP is valued cheaply inside the industry as 97.53% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.37 | ||
| EV/EBITDA | 8.09 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IDP does not grow enough to justify the current Price/Earnings ratio.
- IDP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.21
PEG (5Y)N/A
EPS Next 2Y3.4%
EPS Next 3Y3.98%
5. IDP.DE Dividend Analysis
5.1 Amount
- IDP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IDP.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:IDP (4/24/2026, 7:00:00 PM)
157.02
-3.76 (-2.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-06 2026-02-06/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners98.03%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap23.04B
Revenue(TTM)9.89B
Net Income(TTM)1.29B
Analysts73.02
Price Target183.33 (16.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.18%
Min EPS beat(2)20.87%
Max EPS beat(2)21.48%
EPS beat(4)4
Avg EPS beat(4)24.64%
Min EPS beat(4)17.28%
Max EPS beat(4)38.92%
EPS beat(8)8
Avg EPS beat(8)17.2%
EPS beat(12)12
Avg EPS beat(12)12.76%
EPS beat(16)15
Avg EPS beat(16)12.81%
Revenue beat(2)2
Avg Revenue beat(2)3.75%
Min Revenue beat(2)1.26%
Max Revenue beat(2)6.23%
Revenue beat(4)4
Avg Revenue beat(4)6.45%
Min Revenue beat(4)1.26%
Max Revenue beat(4)11.62%
Revenue beat(8)6
Avg Revenue beat(8)2.98%
Revenue beat(12)9
Avg Revenue beat(12)2.26%
Revenue beat(16)11
Avg Revenue beat(16)1.92%
PT rev (1m)3.56%
PT rev (3m)12.35%
EPS NQ rev (1m)-2.32%
EPS NQ rev (3m)-15.21%
EPS NY rev (1m)0.27%
EPS NY rev (3m)4.37%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)1.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.03 | ||
| Fwd PE | 11.41 | ||
| P/S | 2.73 | ||
| P/FCF | 13.37 | ||
| P/OCF | 12.24 | ||
| P/B | 1.48 | ||
| P/tB | 10.43 | ||
| EV/EBITDA | 8.09 |
EPS(TTM)13.05
EY8.31%
EPS(NY)13.77
Fwd EY8.77%
FCF(TTM)11.75
FCFY7.48%
OCF(TTM)12.83
OCFY8.17%
SpS57.54
BVpS106.22
TBVpS15.05
PEG (NY)2.21
PEG (5Y)N/A
Graham Number176.6 (12.47%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.39% | ||
| ROE | 7.08% | ||
| ROCE | 10.59% | ||
| ROIC | 8.93% | ||
| ROICexc | 10.46% | ||
| ROICexgc | 35.29% | ||
| OM | 27.94% | ||
| PM (TTM) | 13.07% | ||
| GM | 75.69% | ||
| FCFM | 20.42% |
ROA(3y)4.85%
ROA(5y)6.69%
ROE(3y)8.23%
ROE(5y)12.34%
ROIC(3y)8.93%
ROIC(5y)10.93%
ROICexc(3y)9.96%
ROICexc(5y)13.03%
ROICexgc(3y)38.5%
ROICexgc(5y)36.85%
ROCE(3y)10.59%
ROCE(5y)12.95%
ROICexgc growth 3Y4.85%
ROICexgc growth 5Y-4.35%
ROICexc growth 3Y-13.95%
ROICexc growth 5Y-14.37%
OM growth 3Y-3.78%
OM growth 5Y-5.27%
PM growth 3Y-24.15%
PM growth 5Y-15.17%
GM growth 3Y-0.7%
GM growth 5Y-2.57%
F-Score4
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | 3.11 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 23.77% | ||
| Cap/Sales | 1.87% | ||
| Interest Coverage | 10.46 | ||
| Cash Conversion | 62.22% | ||
| Profit Quality | 156.18% | ||
| Current Ratio | 2.68 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | 3.3 |
F-Score4
WACC9.21%
ROIC/WACC0.97
Cap/Depr(3y)46.72%
Cap/Depr(5y)49.51%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.77%
Profit Quality(3y)138.91%
Profit Quality(5y)133.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.16%
EPS 3Y-6.07%
EPS 5Y-14.17%
EPS Q2Q%-42.15%
EPS Next Y5.45%
EPS Next 2Y3.4%
EPS Next 3Y3.98%
EPS Next 5Y4.27%
Revenue 1Y (TTM)2.22%
Revenue growth 3Y-0.93%
Revenue growth 5Y-5.96%
Sales Q2Q%-7.14%
Revenue Next Year-3.54%
Revenue Next 2Y-1.96%
Revenue Next 3Y-0.91%
Revenue Next 5Y0.45%
EBIT growth 1Y8.4%
EBIT growth 3Y-4.68%
EBIT growth 5Y-10.91%
EBIT Next Year17.07%
EBIT Next 3Y5.07%
EBIT Next 5Y1.28%
FCF growth 1Y-19.74%
FCF growth 3Y20.95%
FCF growth 5Y-11.3%
OCF growth 1Y-23.33%
OCF growth 3Y16.78%
OCF growth 5Y-12.22%
BIOGEN INC / IDP.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of BIOGEN INC (IDP.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to IDP.DE.
What is the valuation status for IDP stock?
ChartMill assigns a valuation rating of 7 / 10 to BIOGEN INC (IDP.DE). This can be considered as Undervalued.
How profitable is BIOGEN INC (IDP.DE) stock?
BIOGEN INC (IDP.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for IDP stock?
The Price/Earnings (PE) ratio for BIOGEN INC (IDP.DE) is 12.03 and the Price/Book (PB) ratio is 1.48.
What is the earnings growth outlook for BIOGEN INC?
The Earnings per Share (EPS) of BIOGEN INC (IDP.DE) is expected to grow by 5.45% in the next year.